HL7 Antitrust Policy

Professional Associations, such as HL7, which bring together competing entities are subject to strict scrutiny under applicable antitrust laws. HL7 recognizes that the antitrust laws were enacted to promote fairness in competition and, as such, supports laws against monopoly and restraints of trade and their enforcement. Each individual participating in HL7 meetings and conferences, regardless of venue, is responsible for knowing the contents of and adhering to the HL7 Antitrust Policy as stated in §05.01 of the Governance and Operations Manual (GOM).

Attendees

Please include your organization in your Zoom name.

• Click on your picture/name in Zoom
• Click on rename
• enter <name> - <organization>

Agenda Items and Notes

Outstanding Action Item List

Meeting Notes from previous meeting

• 2022-07-11 Agenda/Meeting Notes - accepted by general consent

Project Review

Project Proposals

• Project Proposals in Review - none to review

Project Scope Statements

• Project Scope Statements
  • PSS-2102 - Getting issue details... STATUS - Electronic Product Information FHIR Implementation Guide
    • international standard for electronic structured patient information
    • suggest that Pharmacy become an interested party for this project

External Meeting Review

Catalog Updates (John Hatem)

• Updates cancelled over the summer

Workflow Update (John Hatem) 

• Updates cancelled over the summer

Healthcare Product Update (John Hatem)

• Updates cancelled over the summer

EHR conformant reconciled medication list (cRML) (Scott Robertson / John Hatem)

• Update from 14 July call - no update
• HL7 EHR WG/Reducing Clinician Burden
  • Related Meeting Schedule https://confluence.hl7.org/pages/viewpage.action?pageId=104568480#ReducingClinicianBurden(RCB)-HL7EHRWG/ReducingClinicianBurdenRelatedMeetingSchedule every other week starting on July 14 https://meet.goto.com/645768157

NCPDP Updates (NCPDP Members)

All NCPDP Meeting information can be obtained at https://dms.ncpdp.org/

WG18 Patient Consent TG:

• specification is in the ballot for September

MC Consumer and Provider RTPB Standards Monitoring Sub-Task Group

• group is on hiatus

Projects

PDex Formulary (Corey)

• Vote on Jira issues:
  
  • FHIR-37717 - Getting issue details... STATUS Add guidance for granular pharmacy benefits
    • coverage details may be more granular than an RxNorm Code
    • added additional guidance under Use Cases
    • Corey has received an email that he needs to review 
  • FHIR-36330 - Getting issue details... STATUS Provide more guidance for authenticated access 
    • Motion to approve - Corey Spears - Dave Hill - Carried - 9-0-0
  • FHIR-37623 - Getting issue details... STATUS String and Token Search Parameters for FormularyDrug (DrugName, DrugTier, and DrugPlan) incorrectly include the comparator "eq"
    • Motion to approve - Corey Spears - Dave Hill - 9-0-0 Carried
• Publication Request - will ask for a review of the updated version with FHIR-37717 unapproved at this time
  • will bring publication request - 
  • https://build.fhir.org/ig/HL7/davinci-pdex-formulary/branches/stu2-pub/
    • includes all of the changes including the one still in review
  • Please review in advance of next weeks call - will bring forward publication request next week in addition to one remaining issue

Pharmacist Consult Note (Scott)

• Update: no update

Trackers - link to pharmacy unresolved Jira trackers (see trackers for details / resolutions)

• None to review

Any Other Business

• PACIO Project (Shelly)
  • looking to review structural modelling approaches - FHIR based post acute care orders - may include MedicationRequest
    
    • this is in the scope of Advanced Directives IG
    • early in the process - will come to Pharmacy if necessary
• Pharmacy WG Co-chair election
  • encourage people to consider putting their name forward
• WGM Agenda - draft created

Next meeting:

• 25 Jul 2022